BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38525515)

  • 1. Evolution of Testicular Germ Cell Tumors in the Molecular Era With Histogenetic Implications.
    Kilic I; Acosta AM; Idrees MT
    Adv Anat Pathol; 2024 May; 31(3):206-214. PubMed ID: 38525515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic markers for germ cell neoplasms: from placental-like alkaline phosphatase to micro-RNAs.
    Rajpert-De Meyts E; Nielsen JE; Skakkebaek NE; Almstrup K
    Folia Histochem Cytobiol; 2015; 53(3):177-88. PubMed ID: 26306513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The oncogene Gankyrin is expressed in testicular cancer and contributes to cisplatin sensitivity in embryonal carcinoma cells.
    Camacho-Moll ME; Macdonald J; Looijenga LHJ; Rimmer MP; Donat R; Marwick JA; Shukla CJ; Carragher N; Jørgensen A; Mitchell RT
    BMC Cancer; 2019 Nov; 19(1):1124. PubMed ID: 31744479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of intratubular seminoma and intratubular embryonal carcinoma with invasive testicular germ cell tumors.
    Lau SK; Weiss LM; Chu PG
    Am J Surg Pathol; 2007 Jul; 31(7):1045-9. PubMed ID: 17592271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosomes and expression in human testicular germ-cell tumors: insight into their cell of origin and pathogenesis.
    Looijenga LH; Gillis AJ; Stoop HJ; Hersmus R; Oosterhuis JW
    Ann N Y Acad Sci; 2007 Dec; 1120():187-214. PubMed ID: 17911410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers: IV: Current and Future Utilization of Molecular-Genetic Tests for Testicular Germ Cell Tumors.
    Looijenga LHJ; Van der Kwast TH; Grignon D; Egevad L; Kristiansen G; Kao CS; Idrees MT
    Am J Surg Pathol; 2020 Jul; 44(7):e66-e79. PubMed ID: 32205480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seminoma component of mixed testicular germ cell tumor shows a higher incidence of loss of heterozygosity than pure-type seminoma.
    Miyai K; Ito K; Nakanishi K; Tsuda H
    Hum Pathol; 2019 Feb; 84():71-80. PubMed ID: 30266250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global DNA hypomethylation in intratubular germ cell neoplasia and seminoma, but not in nonseminomatous male germ cell tumors.
    Netto GJ; Nakai Y; Nakayama M; Jadallah S; Toubaji A; Nonomura N; Albadine R; Hicks JL; Epstein JI; Yegnasubramanian S; Nelson WG; De Marzo AM
    Mod Pathol; 2008 Nov; 21(11):1337-44. PubMed ID: 18622385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-to-cell variation of chromosomal number in the adult testicular germ cell tumors: a comparison of chromosomal instability among histological components and its putative role in tumor progression.
    Miyai K; Ito K; Nakanishi K; Tsuda H
    Virchows Arch; 2019 Jun; 474(6):711-720. PubMed ID: 30877382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnostic value of immunohistochemistry and FISH for chromosome 12p in type Ⅱ testicular germ cell tumors].
    Shen Q; Rao Q; Yu B; Xia QY; Bao W; Lu ZF; Shi QL; Zhou XJ
    Zhonghua Nan Ke Xue; 2016 Aug; 22(8):692-697. PubMed ID: 29019224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of
    Timmerman DM; Eleveld TF; Gillis AJM; Friedrichs CC; Hillenius S; Remmers TL; Sriram S; Looijenga LHJ
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intratubular germ cell neoplasia of the human testis: heterogeneous protein expression and relation to invasive potential.
    Mitchell RT; Camacho-Moll M; Macdonald J; Anderson RA; Kelnar CJ; O'Donnell M; Sharpe RM; Smith LB; Grigor KM; Wallace WHB; Stoop H; Wolffenbuttel KP; Donat R; Saunders PT; Looijenga LH
    Mod Pathol; 2014 Sep; 27(9):1255-1266. PubMed ID: 24457464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testicular Tumors: A Contemporary Update on Morphologic, Immunohistochemical and Molecular Features.
    Al-Obaidy KI; Idrees MT
    Adv Anat Pathol; 2021 Jul; 28(4):258-275. PubMed ID: 33871428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. c-KIT is frequently mutated in bilateral germ cell tumours and down-regulated during progression from intratubular germ cell neoplasia to seminoma.
    Biermann K; Göke F; Nettersheim D; Eckert D; Zhou H; Kahl P; Gashaw I; Schorle H; Büttner R
    J Pathol; 2007 Nov; 213(3):311-8. PubMed ID: 17768701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic analysis of spermatocytic tumors demonstrates recurrent molecular alterations in cases with malignant clinical behavior.
    Gupta S; Sholl LM; Yang Y; Osunkoya AO; Gordetsky JB; Cornejo KM; Michalova K; Maclean F; Dvindenko E; Snuderl M; Hirsch MS; Anderson WJ; Rowsey RA; Jimenez RE; Cheville JC; Sadow PM; Colecchia M; Ricci C; Ulbright TM; Berney DM; Acosta AM
    J Pathol; 2024 Jan; 262(1):50-60. PubMed ID: 37792634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current knowledge of risk factors for testicular germ cell tumors.
    Fukawa T; Kanayama HO
    Int J Urol; 2018 Apr; 25(4):337-344. PubMed ID: 29345008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Testicular germ cell tumors: Histopathological and molecular features].
    Tourne M; Radulescu C; Allory Y
    Bull Cancer; 2019 Apr; 106(4):328-341. PubMed ID: 30905378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-wide expression profiling reveals new insights into pathogenesis and progression of testicular germ cell tumors.
    Biermann K; Heukamp LC; Steger K; Zhou H; Franke FE; Sonnack V; Brehm R; Berg J; Bastian PJ; Muller SC; Wang-Eckert L; Buettner R
    Cancer Genomics Proteomics; 2007; 4(5):359-67. PubMed ID: 17993720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent developments in testicular germ cell tumor research.
    van de Geijn GJ; Hersmus R; Looijenga LH
    Birth Defects Res C Embryo Today; 2009 Mar; 87(1):96-113. PubMed ID: 19306344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RAS/MAPK Pathway Driver Alterations Are Significantly Associated With Oncogenic KIT Mutations in Germ-cell Tumors.
    Mata DA; Yang SR; Ferguson DC; Liu Y; Sharma R; Benhamida JK; Al-Ahmadie HA; Chakravarty D; Solit DB; Tickoo SK; Gupta S; Arcila ME; Ladanyi M; Feldman DR; Reuter VE; Vanderbilt CM
    Urology; 2020 Oct; 144():111-116. PubMed ID: 32721511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.